Was hoping for a " First patient dosed " anns, still some hurdles to come. Probably July? Anyway, better late than never. 3rd generation, auto or allo? Allo is now the way to go but when licensed it wasn't that popular. Maybe they can use allo as well, in the end is just a matter of availability of healthy donor cells or they may use the placenta based cells developed by CELU.
Time will tell.
GLTA
Ann: CHM CDH17 Phase 1/2 clinical trial approved for initiation, page-2
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.29M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.6¢ | $1.596K | 99.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 973796 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 303645 | 1 |
View Market Depth
| Last trade - 11.09am 12/09/2024 (20 minute delay) ? |
| CHM (ASX) Chart |